Pioneer Group Adds NunaBio To Venture Building ProgrammeVicky Coghlan2024-11-28T14:45:20+00:00April 21st, 2023|Investment, News|
Life Science Accelerator Programme: How Cutting-Edge Companies Are Growing Organically At BioCity NottinghamAmy Cotterill2024-11-28T14:46:11+00:00April 17th, 2023|Accelerator, BioCity Nottingham, Investment, News|
NanoSyrinx Joins Life Sciences Incubator In NottinghamAmy Cotterill2024-11-28T14:47:44+00:00March 27th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Life Sciences Investment Showcase: Connecting Entrepreneurs With Expert Growth FacilitatorsAmy Cotterill2025-05-19T11:40:04+01:00March 23rd, 2023|Accelerator, Article, Investment|
Life Sciences Investing: Pioneer Group Reinvests In Biotech Firm NuVisionVicky Coghlan2024-11-28T14:48:12+00:00March 9th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Five Questions With Harry Pickering, Portfolio Director & Head Of UK InvestmentVicky Coghlan2024-11-28T14:48:26+00:00February 21st, 2023|Article, Headline Article, Investment|
Pioneer Group Tenant MIP Discovery Secure Funding From Bill & Melinda Gates FoundationVicky Coghlan2023-04-03T14:24:52+01:00February 16th, 2023|Colworth Park, News|
£20m Series A Funding For Two Pioneer Group Accelerator Programme GraduatesVicky Coghlan2023-03-09T15:14:09+00:00February 15th, 2023|Accelerator, Headline Article, News|
Pioneer Group Announce Lead Investment In Selentus ScienceVicky Coghlan2024-11-28T14:49:26+00:00February 7th, 2023|BioCity Nottingham, Investment, News|
AbbVie And Pioneer Group Name NanoSyrinx As The Winner Of The 2022 AbbVie UK Golden Ticket ProgrammeGemma Cann2025-03-20T15:50:40+00:00September 27th, 2022|Accelerator, News|
